Liver transplantation remains the only curative option for some patients, but pharmacological blockage of galectin-3 may offer elegant approaches for inhibiting cirrhosis progression and HCC, thereby reducing needs for transplantation. The gene discussed is LGALS3; the disease is Cirrhosis.